These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27837030)

  • 1. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
    Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
    Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
    Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
    Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
    J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
    Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
    Abdel-Fatah TM; Arora A; Alsubhi N; Agarwal D; Moseley PM; Perry C; Doherty R; Chan SY; Green AR; Rakha E; Ball G; Ellis IO; Madhusudan S
    Neoplasia; 2014 Nov; 16(11):982-91. PubMed ID: 25425972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.
    Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H
    PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
    Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
    Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
    Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
    Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RECQL4 helicase has oncogenic potential in sporadic breast cancers.
    Arora A; Agarwal D; Abdel-Fatah TM; Lu H; Croteau DL; Moseley P; Aleskandarany MA; Green AR; Ball G; Rakha EA; Chan SY; Ellis IO; Wang LL; Zhao Y; Balajee AS; Bohr VA; Madhusudan S
    J Pathol; 2016 Mar; 238(4):495-501. PubMed ID: 26690729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
    Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
    Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
    Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
    Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
    Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
    Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
    Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase.
    Futami K; Kumagai E; Makino H; Goto H; Takagi M; Shimamoto A; Furuichi Y
    Cancer Sci; 2008 Jan; 99(1):71-80. PubMed ID: 17953710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RECQL1 plays an important role in the development of tongue squamous cell carcinoma.
    Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y
    Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
    Kenny FS; Hui R; Musgrove EA; Gee JM; Blamey RW; Nicholson RI; Sutherland RL; Robertson JF
    Clin Cancer Res; 1999 Aug; 5(8):2069-76. PubMed ID: 10473088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors for Luminal B-like Breast Cancer.
    Ding NH; Liu CF; Hu C; Yuan JQ; Liao WH; Xiao Z
    Curr Med Sci; 2019 Jun; 39(3):396-402. PubMed ID: 31209809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes.
    Joseph C; Macnamara O; Craze M; Russell R; Provenzano E; Nolan CC; Diez-Rodriguez M; Sonbul SN; Aleskandarany MA; Green AR; Rakha EA; Ellis IO; Mukherjee A
    Br J Cancer; 2018 Apr; 118(8):1142-1151. PubMed ID: 29588513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.